Wealth Enhancement Advisory Services’s Evolent Health EVH Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$146K	Buy	+24,833	New	+$95.2K	﹤0.01%	3704

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Wealth Enhancement Advisory Services's EVH Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Evolent Health (EVH) in Q2 2026: 24,833 shares worth $146K. The stake represents ﹤0.01% of the portfolio and ranks #3704 among its holdings.

198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

Wealth Enhancement Advisory Services held 24,833 shares of Evolent Health worth $146K as of Q2 2026.
Evolent Health was a new Wealth Enhancement Advisory Services position in Q2 2026.
Evolent Health made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3704 holding.
198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.